Can tocotrienol reduce time to the first serious adverse event during treatment with FOLFOXIRI for colorectal cancer?

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalAnnals of Oncology
Volume30
Issue numberSuppl. 5
Pages (from-to)v871
Number of pages1
ISSN0923-7534
DOIs
Publication statusPublished - 2019
EventESMO Congress 2019 : Translating science into better cancer patient care​ - Barcelona, Spain
Duration: 27. Sep 20191. Oct 2019
https://www.esmo.org/Conferences/Past-Conferences/ESMO-Congress-2019​

Conference

ConferenceESMO Congress 2019
CountrySpain
CityBarcelona
Period27/09/201901/10/2019
Internet address

Cite this